 Robert Meguid
Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Complications | 51 | 2023 | 2164 | 9.330 |
Why?
| | Esophagectomy | 15 | 2023 | 111 | 4.600 |
Why?
| | Esophageal Neoplasms | 15 | 2023 | 273 | 4.310 |
Why?
| | Surgical Procedures, Operative | 9 | 2021 | 210 | 4.100 |
Why?
| | Surgeons | 7 | 2023 | 238 | 3.400 |
Why?
| | Quality Improvement | 22 | 2023 | 958 | 3.110 |
Why?
| | Robotic Surgical Procedures | 7 | 2024 | 88 | 2.970 |
Why?
| | Risk Assessment | 25 | 2023 | 2992 | 2.950 |
Why?
| | Inpatients | 5 | 2023 | 380 | 2.700 |
Why?
| | Thoracic Surgery | 5 | 2023 | 105 | 2.700 |
Why?
| | Pneumonectomy | 7 | 2023 | 126 | 2.650 |
Why?
| | Preoperative Care | 6 | 2021 | 318 | 2.340 |
Why?
| | Lung Neoplasms | 11 | 2023 | 2206 | 2.300 |
Why?
| | Urinary Tract Infections | 4 | 2022 | 136 | 2.110 |
Why?
| | Retrospective Studies | 54 | 2023 | 12616 | 2.100 |
Why?
| | Electronic Health Records | 7 | 2023 | 805 | 2.060 |
Why?
| | Databases, Factual | 19 | 2023 | 1137 | 2.050 |
Why?
| | Specialties, Surgical | 3 | 2023 | 71 | 1.730 |
Why?
| | Surgical Wound Infection | 6 | 2023 | 251 | 1.620 |
Why?
| | Risk Factors | 29 | 2023 | 8715 | 1.610 |
Why?
| | Patient Readmission | 7 | 2023 | 609 | 1.600 |
Why?
| | Hospital Mortality | 11 | 2022 | 779 | 1.500 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 6 | 2023 | 964 | 1.460 |
Why?
| | Sepsis | 4 | 2023 | 521 | 1.370 |
Why?
| | Humans | 110 | 2024 | 115879 | 1.360 |
Why?
| | Emergency Treatment | 2 | 2021 | 115 | 1.350 |
Why?
| | Informed Consent | 2 | 2020 | 163 | 1.310 |
Why?
| | Hospitals | 7 | 2022 | 585 | 1.290 |
Why?
| | Thoracic Surgical Procedures | 4 | 2023 | 57 | 1.230 |
Why?
| | Intensive Care Units | 2 | 2022 | 624 | 1.210 |
Why?
| | Models, Statistical | 4 | 2020 | 612 | 1.210 |
Why?
| | Aged | 34 | 2023 | 19296 | 1.060 |
Why?
| | Middle Aged | 40 | 2023 | 27085 | 1.060 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2023 | 48 | 1.040 |
Why?
| | Laparoscopy | 4 | 2023 | 400 | 1.020 |
Why?
| | Patient Discharge | 3 | 2020 | 770 | 1.010 |
Why?
| | Lung Transplantation | 7 | 2023 | 246 | 0.980 |
Why?
| | United States | 28 | 2023 | 12322 | 0.960 |
Why?
| | Shock, Septic | 2 | 2023 | 185 | 0.940 |
Why?
| | Metastasectomy | 1 | 2023 | 12 | 0.890 |
Why?
| | Hernia, Hiatal | 1 | 2023 | 32 | 0.880 |
Why?
| | Hypothermia | 1 | 2023 | 38 | 0.870 |
Why?
| | General Surgery | 4 | 2021 | 130 | 0.860 |
Why?
| | Logistic Models | 9 | 2023 | 1863 | 0.850 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2023 | 208 | 0.810 |
Why?
| | Male | 49 | 2023 | 56117 | 0.800 |
Why?
| | Critical Pathways | 1 | 2022 | 75 | 0.800 |
Why?
| | Adult | 32 | 2023 | 30822 | 0.800 |
Why?
| | Female | 47 | 2023 | 60082 | 0.780 |
Why?
| | Treatment Outcome | 19 | 2023 | 9164 | 0.770 |
Why?
| | Length of Stay | 7 | 2023 | 960 | 0.770 |
Why?
| | Patient Admission | 1 | 2022 | 175 | 0.740 |
Why?
| | Surgery Department, Hospital | 1 | 2020 | 21 | 0.730 |
Why?
| | Thoracic Surgery, Video-Assisted | 2 | 2019 | 40 | 0.710 |
Why?
| | Rectal Prolapse | 1 | 2020 | 18 | 0.700 |
Why?
| | Patient Satisfaction | 2 | 2022 | 585 | 0.700 |
Why?
| | Cohort Studies | 11 | 2023 | 4960 | 0.700 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 234 | 0.670 |
Why?
| | Thoracotomy | 1 | 2019 | 67 | 0.670 |
Why?
| | Outpatients | 1 | 2022 | 330 | 0.650 |
Why?
| | Cardiac Surgical Procedures | 1 | 2023 | 414 | 0.650 |
Why?
| | Aftercare | 1 | 2020 | 187 | 0.640 |
Why?
| | Minimally Invasive Surgical Procedures | 5 | 2023 | 154 | 0.630 |
Why?
| | Thoracoscopy | 2 | 2020 | 53 | 0.630 |
Why?
| | Patient Transfer | 2 | 2019 | 143 | 0.630 |
Why?
| | Hospitals, Teaching | 2 | 2009 | 103 | 0.620 |
Why?
| | Pancreatic Neoplasms | 2 | 2023 | 722 | 0.600 |
Why?
| | Morbidity | 4 | 2023 | 278 | 0.570 |
Why?
| | Preoperative Period | 4 | 2021 | 103 | 0.560 |
Why?
| | Tissue and Organ Procurement | 4 | 2023 | 243 | 0.540 |
Why?
| | Prognosis | 7 | 2023 | 3344 | 0.520 |
Why?
| | Postoperative Care | 2 | 2016 | 222 | 0.520 |
Why?
| | Survival Rate | 9 | 2023 | 1650 | 0.500 |
Why?
| | Data Collection | 1 | 2017 | 637 | 0.490 |
Why?
| | Trachea | 1 | 2016 | 233 | 0.480 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 216 | 0.470 |
Why?
| | Machine Learning | 4 | 2023 | 320 | 0.470 |
Why?
| | Adenocarcinoma | 3 | 2023 | 798 | 0.460 |
Why?
| | Quality of Life | 2 | 2024 | 2390 | 0.450 |
Why?
| | Ischemic Preconditioning | 2 | 2023 | 28 | 0.440 |
Why?
| | Anastomotic Leak | 3 | 2023 | 28 | 0.420 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2011 | 115 | 0.410 |
Why?
| | Patient Reported Outcome Measures | 3 | 2024 | 250 | 0.400 |
Why?
| | Veterans | 1 | 2022 | 1233 | 0.380 |
Why?
| | Aged, 80 and over | 9 | 2023 | 6434 | 0.380 |
Why?
| | Neoplasm Staging | 5 | 2023 | 1177 | 0.370 |
Why?
| | Pregnancy Complications | 1 | 2015 | 431 | 0.370 |
Why?
| | Conversion to Open Surgery | 2 | 2020 | 13 | 0.360 |
Why?
| | Pain, Postoperative | 2 | 2023 | 195 | 0.360 |
Why?
| | Thoracic Neoplasms | 2 | 2020 | 33 | 0.350 |
Why?
| | Propensity Score | 3 | 2019 | 225 | 0.340 |
Why?
| | Neoadjuvant Therapy | 2 | 2021 | 301 | 0.340 |
Why?
| | Time Factors | 7 | 2023 | 6182 | 0.330 |
Why?
| | Aneurysm, Ruptured | 1 | 2009 | 34 | 0.330 |
Why?
| | Quality Assurance, Health Care | 3 | 2021 | 315 | 0.320 |
Why?
| | Guideline Adherence | 2 | 2023 | 497 | 0.300 |
Why?
| | Reoperation | 2 | 2023 | 525 | 0.300 |
Why?
| | Triage | 2 | 2020 | 192 | 0.300 |
Why?
| | Disease-Free Survival | 3 | 2023 | 621 | 0.290 |
Why?
| | Pancreatic Diseases | 1 | 2008 | 64 | 0.290 |
Why?
| | Reproducibility of Results | 3 | 2019 | 2807 | 0.280 |
Why?
| | Pancreaticoduodenectomy | 1 | 2008 | 130 | 0.280 |
Why?
| | Pneumonia | 2 | 2023 | 576 | 0.280 |
Why?
| | Diaphragm | 2 | 2023 | 33 | 0.280 |
Why?
| | Chylothorax | 2 | 2017 | 11 | 0.280 |
Why?
| | Pancreatectomy | 1 | 2008 | 169 | 0.270 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 222 | 0.270 |
Why?
| | Quality Indicators, Health Care | 2 | 2020 | 287 | 0.260 |
Why?
| | Postoperative Hemorrhage | 2 | 2023 | 78 | 0.250 |
Why?
| | Feasibility Studies | 2 | 2019 | 750 | 0.250 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 344 | 0.250 |
Why?
| | Coronavirus Infections | 2 | 2020 | 336 | 0.240 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3072 | 0.240 |
Why?
| | Smoking | 2 | 2012 | 1465 | 0.230 |
Why?
| | Comorbidity | 3 | 2022 | 1476 | 0.220 |
Why?
| | Respiratory Paralysis | 1 | 2023 | 3 | 0.220 |
Why?
| | Herniorrhaphy | 1 | 2023 | 51 | 0.220 |
Why?
| | Algorithms | 3 | 2019 | 1494 | 0.220 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2023 | 863 | 0.210 |
Why?
| | Fluorouracil | 1 | 2023 | 151 | 0.210 |
Why?
| | Risk Adjustment | 1 | 2023 | 75 | 0.210 |
Why?
| | Pandemics | 4 | 2023 | 1339 | 0.210 |
Why?
| | Advisory Committees | 1 | 2023 | 208 | 0.200 |
Why?
| | Colorectal Surgery | 1 | 2022 | 22 | 0.200 |
Why?
| | Tissue Donors | 2 | 2023 | 331 | 0.200 |
Why?
| | Heart Transplantation | 2 | 2023 | 671 | 0.190 |
Why?
| | Focus Groups | 1 | 2023 | 387 | 0.190 |
Why?
| | Databases as Topic | 1 | 2021 | 63 | 0.190 |
Why?
| | Lung | 2 | 2024 | 3683 | 0.190 |
Why?
| | Fear | 1 | 2023 | 296 | 0.180 |
Why?
| | Prospective Studies | 4 | 2024 | 6279 | 0.180 |
Why?
| | Arthroplasty | 1 | 2020 | 50 | 0.180 |
Why?
| | Betacoronavirus | 2 | 2020 | 254 | 0.180 |
Why?
| | Robotics | 1 | 2021 | 79 | 0.180 |
Why?
| | Intermediate Care Facilities | 1 | 2019 | 3 | 0.170 |
Why?
| | Education, Medical, Graduate | 2 | 2017 | 378 | 0.170 |
Why?
| | Emergencies | 1 | 2021 | 150 | 0.170 |
Why?
| | Elective Surgical Procedures | 1 | 2021 | 154 | 0.170 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1999 | 34 | 0.170 |
Why?
| | Benchmarking | 1 | 2021 | 163 | 0.170 |
Why?
| | Societies, Medical | 1 | 2023 | 685 | 0.170 |
Why?
| | Physical Fitness | 1 | 2020 | 179 | 0.170 |
Why?
| | Glutamine | 1 | 1999 | 90 | 0.170 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 89 | 0.160 |
Why?
| | Geography | 1 | 2019 | 183 | 0.160 |
Why?
| | Heat-Shock Proteins | 1 | 1999 | 113 | 0.160 |
Why?
| | Overweight | 1 | 2023 | 468 | 0.160 |
Why?
| | Datasets as Topic | 1 | 2019 | 99 | 0.160 |
Why?
| | United States Department of Veterans Affairs | 1 | 2022 | 557 | 0.160 |
Why?
| | Internship and Residency | 3 | 2021 | 957 | 0.160 |
Why?
| | Incidence | 2 | 2023 | 2336 | 0.160 |
Why?
| | Hospitals, University | 1 | 2018 | 172 | 0.160 |
Why?
| | Medical Oncology | 1 | 2020 | 230 | 0.150 |
Why?
| | Skilled Nursing Facilities | 1 | 2019 | 119 | 0.150 |
Why?
| | Forecasting | 1 | 2019 | 333 | 0.150 |
Why?
| | Qualitative Research | 1 | 2022 | 967 | 0.150 |
Why?
| | Eating | 3 | 1995 | 349 | 0.150 |
Why?
| | Altruism | 1 | 2017 | 25 | 0.150 |
Why?
| | Clinical Competence | 3 | 2021 | 924 | 0.150 |
Why?
| | Pain Management | 1 | 2020 | 291 | 0.140 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 231 | 0.140 |
Why?
| | Thoracic Wall | 1 | 2017 | 15 | 0.140 |
Why?
| | Self Efficacy | 1 | 2020 | 361 | 0.140 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 255 | 0.140 |
Why?
| | Gastric Outlet Obstruction | 1 | 2017 | 7 | 0.140 |
Why?
| | Pylorus | 1 | 2017 | 11 | 0.140 |
Why?
| | Pleural Effusion | 1 | 2017 | 46 | 0.140 |
Why?
| | Models, Theoretical | 1 | 2021 | 520 | 0.140 |
Why?
| | Medically Underserved Area | 1 | 2017 | 80 | 0.140 |
Why?
| | Parenteral Nutrition | 2 | 1995 | 93 | 0.140 |
Why?
| | Frailty | 1 | 2019 | 116 | 0.140 |
Why?
| | Soft Tissue Infections | 1 | 2017 | 30 | 0.140 |
Why?
| | Abscess | 1 | 2017 | 73 | 0.140 |
Why?
| | Prevalence | 1 | 2022 | 2270 | 0.140 |
Why?
| | Home Care Services | 1 | 2019 | 226 | 0.140 |
Why?
| | Neuromuscular Agents | 1 | 2017 | 30 | 0.140 |
Why?
| | Botulinum Toxins, Type A | 1 | 2017 | 40 | 0.140 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2019 | 243 | 0.140 |
Why?
| | Postoperative Period | 4 | 2021 | 292 | 0.130 |
Why?
| | Environmental Exposure | 1 | 2019 | 380 | 0.130 |
Why?
| | Chyle | 1 | 2015 | 3 | 0.130 |
Why?
| | Altitude | 1 | 2019 | 409 | 0.130 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1443 | 0.130 |
Why?
| | Health Status | 1 | 2021 | 728 | 0.130 |
Why?
| | Osteomyelitis | 1 | 2017 | 105 | 0.130 |
Why?
| | Nutritional Support | 1 | 2015 | 27 | 0.130 |
Why?
| | Body Mass Index | 1 | 2023 | 1974 | 0.130 |
Why?
| | Monitoring, Intraoperative | 1 | 2015 | 39 | 0.130 |
Why?
| | Factor Analysis, Statistical | 1 | 2016 | 261 | 0.130 |
Why?
| | Orthopedics | 1 | 2017 | 125 | 0.130 |
Why?
| | Biomedical Research | 1 | 2021 | 589 | 0.120 |
Why?
| | Patient-Centered Care | 1 | 2020 | 477 | 0.120 |
Why?
| | Healthcare Disparities | 1 | 2020 | 487 | 0.120 |
Why?
| | Radiosurgery | 1 | 2018 | 298 | 0.120 |
Why?
| | Hospitalization | 2 | 2021 | 1766 | 0.120 |
Why?
| | Proportional Hazards Models | 3 | 2018 | 1088 | 0.120 |
Why?
| | Colorado | 3 | 2018 | 4122 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1725 | 0.120 |
Why?
| | Hospitals, Veterans | 1 | 2015 | 245 | 0.120 |
Why?
| | Hypotension | 1 | 2015 | 116 | 0.120 |
Why?
| | Research Design | 1 | 2020 | 949 | 0.120 |
Why?
| | Age Factors | 1 | 2021 | 2911 | 0.110 |
Why?
| | Case-Control Studies | 4 | 2022 | 3054 | 0.110 |
Why?
| | Proteins | 1 | 1999 | 920 | 0.110 |
Why?
| | Decision Making | 1 | 2020 | 791 | 0.110 |
Why?
| | Health Services Research | 1 | 2016 | 377 | 0.110 |
Why?
| | Stomach | 2 | 2023 | 101 | 0.110 |
Why?
| | RNA, Messenger | 2 | 1999 | 2581 | 0.110 |
Why?
| | Leiomyosarcoma | 1 | 2012 | 24 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1405 | 0.110 |
Why?
| | DNA-Binding Proteins | 1 | 1999 | 1318 | 0.110 |
Why?
| | Energy Intake | 1 | 1995 | 413 | 0.100 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 73 | 0.100 |
Why?
| | Heart Neoplasms | 1 | 2012 | 50 | 0.100 |
Why?
| | Follow-Up Studies | 3 | 2019 | 4444 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1182 | 0.100 |
Why?
| | Pulmonary Emphysema | 1 | 2015 | 318 | 0.100 |
Why?
| | Endoleak | 1 | 2011 | 13 | 0.100 |
Why?
| | Intestinal Fistula | 1 | 2011 | 12 | 0.100 |
Why?
| | Transcription Factors | 1 | 1999 | 1535 | 0.100 |
Why?
| | Duodenal Diseases | 1 | 2011 | 10 | 0.100 |
Why?
| | Heart Valve Diseases | 1 | 2012 | 118 | 0.100 |
Why?
| | Pulmonary Valve | 1 | 2012 | 90 | 0.100 |
Why?
| | Body Composition | 1 | 1995 | 579 | 0.090 |
Why?
| | Adipose Tissue | 1 | 1995 | 553 | 0.090 |
Why?
| | Transplant Recipients | 2 | 2023 | 143 | 0.090 |
Why?
| | Obesity | 1 | 2023 | 2523 | 0.090 |
Why?
| | Aortic Diseases | 1 | 2011 | 95 | 0.090 |
Why?
| | Hospitals, District | 1 | 2009 | 4 | 0.090 |
Why?
| | Anastomosis, Surgical | 2 | 2023 | 140 | 0.090 |
Why?
| | Pancreas, Exocrine | 1 | 2008 | 8 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 4675 | 0.080 |
Why?
| | Patient Selection | 3 | 2020 | 655 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 501 | 0.080 |
Why?
| | Consensus | 2 | 2020 | 531 | 0.070 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 228 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 526 | 0.070 |
Why?
| | SEER Program | 1 | 2008 | 195 | 0.070 |
Why?
| | Lymphatic Metastasis | 1 | 2008 | 276 | 0.070 |
Why?
| | Hypertension | 1 | 2015 | 1065 | 0.070 |
Why?
| | Precancerous Conditions | 1 | 2008 | 156 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 445 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1032 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 1115 | 0.070 |
Why?
| | Cause of Death | 1 | 2008 | 368 | 0.070 |
Why?
| | Vascular Surgical Procedures | 1 | 2009 | 262 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 685 | 0.060 |
Why?
| | Graft Survival | 2 | 2023 | 481 | 0.060 |
Why?
| | Glypicans | 1 | 2023 | 9 | 0.060 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 816 | 0.060 |
Why?
| | Pregnancy | 1 | 2015 | 5555 | 0.060 |
Why?
| | Triglycerides | 2 | 2015 | 471 | 0.050 |
Why?
| | Odds Ratio | 2 | 2019 | 968 | 0.050 |
Why?
| | Adolescent | 3 | 2023 | 17940 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2008 | 2417 | 0.050 |
Why?
| | Neurosurgical Procedures | 1 | 2023 | 157 | 0.050 |
Why?
| | Dyspnea | 1 | 2023 | 224 | 0.050 |
Why?
| | Colectomy | 1 | 2022 | 87 | 0.050 |
Why?
| | Fatigue | 1 | 2023 | 296 | 0.050 |
Why?
| | Esophagogastric Junction | 1 | 2021 | 42 | 0.050 |
Why?
| | Induction Chemotherapy | 1 | 2021 | 56 | 0.050 |
Why?
| | Tumor Cells, Cultured | 2 | 1999 | 850 | 0.050 |
Why?
| | Child | 1 | 2020 | 18539 | 0.050 |
Why?
| | Learning Curve | 1 | 2021 | 65 | 0.050 |
Why?
| | Professional Practice Gaps | 1 | 2020 | 10 | 0.050 |
Why?
| | Comparative Effectiveness Research | 1 | 2021 | 130 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1814 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2021 | 187 | 0.040 |
Why?
| | Margins of Excision | 1 | 2019 | 29 | 0.040 |
Why?
| | Glutaminase | 1 | 1999 | 9 | 0.040 |
Why?
| | Transcription Factor CHOP | 1 | 1999 | 28 | 0.040 |
Why?
| | Walk Test | 1 | 2019 | 53 | 0.040 |
Why?
| | Hydrolysis | 1 | 1999 | 179 | 0.040 |
Why?
| | Evidence-Based Practice | 1 | 2021 | 191 | 0.040 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2023 | 638 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2020 | 147 | 0.040 |
Why?
| | Serum Albumin | 1 | 2019 | 135 | 0.040 |
Why?
| | Molecular Chaperones | 1 | 1999 | 157 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2009 | 309 | 0.040 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 249 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 66 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 452 | 0.040 |
Why?
| | Needs Assessment | 1 | 2020 | 320 | 0.040 |
Why?
| | Alternative Splicing | 1 | 1999 | 187 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2020 | 352 | 0.040 |
Why?
| | Occupational Health | 1 | 2020 | 168 | 0.040 |
Why?
| | Cell Division | 1 | 1999 | 760 | 0.040 |
Why?
| | HIV Infections | 1 | 2012 | 2471 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 273 | 0.040 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2017 | 13 | 0.040 |
Why?
| | Cell Line | 2 | 1999 | 2657 | 0.040 |
Why?
| | Clinical Audit | 1 | 2016 | 11 | 0.040 |
Why?
| | Education | 1 | 2017 | 99 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2017 | 66 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2019 | 423 | 0.040 |
Why?
| | Regression Analysis | 1 | 2019 | 960 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 1999 | 389 | 0.040 |
Why?
| | Patient Safety | 1 | 2020 | 276 | 0.040 |
Why?
| | Gastric Emptying | 1 | 2017 | 40 | 0.040 |
Why?
| | Operative Time | 1 | 2016 | 109 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2023 | 2750 | 0.030 |
Why?
| | Cadaver | 1 | 2017 | 316 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2023 | 2196 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1379 | 0.030 |
Why?
| | Electrolytes | 1 | 2015 | 55 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1999 | 703 | 0.030 |
Why?
| | Infection Control | 1 | 2016 | 137 | 0.030 |
Why?
| | Dietary Fiber | 1 | 2015 | 40 | 0.030 |
Why?
| | Micronutrients | 1 | 2015 | 77 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2015 | 123 | 0.030 |
Why?
| | Dietary Proteins | 1 | 2015 | 126 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2377 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1127 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1995 | 149 | 0.030 |
Why?
| | Poverty | 1 | 2017 | 444 | 0.030 |
Why?
| | Rats | 4 | 1995 | 5035 | 0.030 |
Why?
| | Glycogen | 1 | 1993 | 52 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 1999 | 1317 | 0.030 |
Why?
| | Dietary Fats | 1 | 2015 | 291 | 0.030 |
Why?
| | Mortality | 1 | 2015 | 290 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 783 | 0.030 |
Why?
| | Staphylococcus epidermidis | 1 | 1993 | 71 | 0.030 |
Why?
| | Anesthesia, General | 1 | 1992 | 44 | 0.030 |
Why?
| | Maryland | 1 | 2012 | 37 | 0.030 |
Why?
| | Echocardiography, Transesophageal | 1 | 2012 | 90 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2012 | 142 | 0.030 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2012 | 64 | 0.030 |
Why?
| | Catheterization, Central Venous | 1 | 1993 | 89 | 0.030 |
Why?
| | Carbon Monoxide | 1 | 2012 | 67 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 563 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1598 | 0.020 |
Why?
| | Peritonitis | 1 | 2011 | 76 | 0.020 |
Why?
| | Body Weight | 1 | 1995 | 868 | 0.020 |
Why?
| | Endoscopy, Digestive System | 1 | 2011 | 109 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2262 | 0.020 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2011 | 181 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 1993 | 338 | 0.020 |
Why?
| | Rats, Inbred F344 | 3 | 1993 | 245 | 0.020 |
Why?
| | California | 1 | 2009 | 368 | 0.020 |
Why?
| | Receptors, Notch | 1 | 2008 | 85 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 1999 | 1872 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 2015 | 731 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1088 | 0.020 |
Why?
| | Safety | 1 | 2009 | 298 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2011 | 270 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2008 | 397 | 0.020 |
Why?
| | Liver | 1 | 1995 | 1693 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2008 | 416 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2008 | 548 | 0.020 |
Why?
| | Animals | 5 | 2008 | 32162 | 0.020 |
Why?
| | Graft Rejection | 1 | 2008 | 533 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 10510 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2008 | 1130 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2008 | 1971 | 0.010 |
Why?
| | Brain | 1 | 1993 | 2372 | 0.010 |
Why?
| | Registries | 1 | 2009 | 1772 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1999 | 194 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 262 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 353 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 328 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 324 | 0.010 |
Why?
| | Isoenzymes | 1 | 1999 | 287 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 523 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1999 | 275 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1999 | 737 | 0.010 |
Why?
| | Signal Transduction | 1 | 2008 | 4528 | 0.010 |
Why?
| | Base Sequence | 1 | 1999 | 2121 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2003 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1999 | 2796 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 178 | 0.010 |
Why?
| | Chloral Hydrate | 1 | 1992 | 3 | 0.010 |
Why?
| | Periodicity | 1 | 1992 | 56 | 0.010 |
Why?
| | Organ Specificity | 1 | 1993 | 274 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 295 | 0.010 |
Why?
| | Mice | 1 | 2008 | 15087 | 0.010 |
Why?
| | Food Preferences | 1 | 1992 | 108 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 1992 | 371 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1993 | 3587 | 0.000 |
Why?
|
|
Meguid's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|